The lipoprotein lipase that is shuttled into capillaries by GPIHBP1 enters the glycocalyx where it mediates lipoprotein processing

Wenxin Song, Anne P. Beigneux, Thomas A. Weston, Kai Chen, Ye Yang, Le Phuong Nguyen, Paul Guagliardo, Hyesoo Jung, Anh P. Tran, Yiping Tu, Caitlyn Tran, Gabriel Birrane, Kazuya Miyashita, Katsuyuki Nakajima, Masami Murakami, Peter Tontonoz, Haibo Jiang, Michael Ploug, Loren G. Fong, Stephen G. YoungProceedings of the National Academy of Sciences 2023 · DOI

Abstract: Lipoprotein lipase (LPL), the enzyme that carries out the lipolytic processing of triglyceride-rich lipoproteins (TRLs), is synthesized by adipocytes and myocytes and secreted into the interstitial spaces. The LPL is then bound by GPIHBP1, a GPI-anchored protein of endothelial cells (ECs), and transported across ECs to the capillary lumen. The assumption has been that the LPL that is moved into capillaries remains attached to GPIHBP1 and that GPIHBP1 serves as a platform for TRL processing. In the current studies, we examined the validity of that assumption. We found that an LPL-specific monoclonal antibody (mAb), 88B8, which lacks the ability to detect GPIHBP1-bound LPL, binds avidly to LPL within capillaries. We further demonstrated, by confocal microscopy, immunogold electron microscopy, and nanoscale secondary ion mass spectrometry analyses, that the LPL detected by mAb 88B8 is located within the EC glycocalyx, distant from the GPIHBP1 on the EC plasma membrane. The LPL within the glycocalyx mediates the margination of TRLs along capillaries and is active in TRL processing, resulting in the delivery of lipoprotein-derived lipids to immediately adjacent parenchymal cells. Thus, the LPL that GPIHBP1 transports into capillaries can detach and move into the EC glycocalyx, where it functions in the intravascular processing of TRLs.

Introduction

To provide energy to muscles and the heart, the body must break down large, fat-carrying particles called triglyceride-rich lipoproteins (TRLs) circulating in the blood. This critical metabolic step is performed by the enzyme Lipoprotein Lipase (LPL). For years, the prevailing model suggested that a protein called GPIHBP1 acted as a stationary "platform," picking up LPL from tissues and anchoring it to the inner surface of capillary walls to process passing TRLs.

However, this model faced significant biophysical challenges. TRLs are massive (often >500 nm) compared to the tiny LPL-GPIHBP1 complex, and the capillary wall is covered by a thick (250–500 nm) "forest" of sugars and proteins called the glycocalyx. It was unclear how these giant particles could reach an enzyme anchored deep at the base of this forest. This study investigates a new hypothesis: LPL detaches from its transporter to reside within the endothelial glycocalyx, creating a functional zone for capturing and processing lipoproteins.

Immunofluorescence imaging of LPL and GPIHBP1 in heart and skeletal muscle capillaries.

Methods

The research team employed a multi-modal imaging strategy to track LPL localization:

  • Monoclonal Antibodies (mAbs): They utilized a specific antibody, 88B8, which only binds to LPL when it is not attached to GPIHBP1. This allowed researchers to distinguish "free" LPL from "shuttled" LPL.
  • Super-Resolution Microscopy: Used to visualize the precise spatial relationship between LPL and the endothelial cell membrane.
  • NanoSIMS (Nanoscale Secondary Ion Mass Spectrometry): This high-tech imaging method mapped the elemental and isotopic composition of tissues, tracking deuterium-labeled ($^2H$) fats as they were processed by LPL and absorbed by heart cells.
  • Genetically Modified Mice: Models lacking LPL or GPIHBP1 were used to isolate the specific functions of the enzyme in different physiological contexts.

Key Results

LPL Detachment and Localization

The study overturned the "platform" model by demonstrating that LPL is not a stationary worker on the cell membrane. Approximately 30% of the LPL inside capillaries was found to be detached from GPIHBP1 and residing in the glycocalyx. Super-resolution imaging confirmed that LPL detected by mAb 88B8 was located within the glycocalyx, physically distant from the GPIHBP1 on the plasma membrane.

Super-resolution imaging and Pearson correlation analysis demonstrate low colocalization between free LPL (88B8) and its transporter GPIHBP1 (11A12), supporting the model of LPL detachment.

Functional Restoration and Nutrient Delivery

In mice lacking their own LPL transport system ($Gpihbp1^{-/-}$), loading the glycocalyx with recombinant LPL was sufficient to restore TRL margination (the sticking of fat particles to the vessel wall) and lipid delivery. Using NanoSIMS, the researchers proved that LPL in the glycocalyx facilitates the entry of fatty acids into heart mitochondria and lipid droplets within just three minutes.

Discussion and Insights

The glycocalyx acts as a functional reservoir rather than just a barrier. It captures LPL via electrostatic forces, holding it in place to "attack" lipoproteins from all sides. This detachment allows the transporter (GPIHBP1) to recycle back to the other side of the cell to pick up more LPL cargo, increasing the efficiency of the transport system.

Interestingly, this binding appears tissue-specific; LPL binds avidly to the glycocalyx in the heart and fat tissue but not in the brain or large arteries. This suggests the glycocalyx has a specific molecular "code" that restricts fat processing to tissues where it is needed for fuel. Future work is required to identify the exact proteoglycans that hold LPL in place and to understand why brain capillaries lack this binding capability.

Reference: Song, W., et al. (2023). The lipoprotein lipase that is shuttled into capillaries by GPIHBP1 enters the glycocalyx where it mediates lipoprotein processing. PNAS, 120(44).

Summary updated

Abstract

Lipoprotein lipase (LPL), the enzyme that carries out the lipolytic processing of triglyceride-rich lipoproteins (TRLs), is synthesized by adipocytes and myocytes and secreted into the interstitial spaces. The LPL is then bound by GPIHBP1, a GPI-anchored protein of endothelial cells (ECs), and transported across ECs to the capillary lumen. The assumption has been that the LPL that is moved into capillaries remains attached to GPIHBP1 and that GPIHBP1 serves as a platform for TRL processing. In the current studies, we examined the validity of that assumption. We found that an LPL-specific monoclonal antibody (mAb), 88B8, which lacks the ability to detect GPIHBP1-bound LPL, binds avidly to LPL within capillaries. We further demonstrated, by confocal microscopy, immunogold electron microscopy, and nanoscale secondary ion mass spectrometry analyses, that the LPL detected by mAb 88B8 is located within the EC glycocalyx, distant from the GPIHBP1 on the EC plasma membrane. The LPL within the glycocalyx mediates the margination of TRLs along capillaries and is active in TRL processing, resulting in the delivery of lipoprotein-derived lipids to immediately adjacent parenchymal cells. Thus, the LPL that GPIHBP1 transports into capillaries can detach and move into the EC glycocalyx, where it functions in the intravascular processing of TRLs.
BibTeX
@inproceedings{song2023lipoprotein,
  author = {Wenxin Song and Anne P. Beigneux and Thomas A. Weston and Kai Chen and Ye Yang and Le Phuong Nguyen and Paul Guagliardo and Hyesoo Jung and Anh P. Tran and Yiping Tu and Caitlyn Tran and Gabriel Birrane and Kazuya Miyashita and Katsuyuki Nakajima and Masami Murakami and Peter Tontonoz and Haibo Jiang and Michael Ploug and Loren G. Fong and Stephen G. Young},
  title = {{The lipoprotein lipase that is shuttled into capillaries by GPIHBP1 enters the glycocalyx where it mediates lipoprotein processing}},
  booktitle = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2313825120},
}
Figure